Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Explainer
Aug 30, 2021
Foreign substances in Japan's Moderna shots: Here's what you need to know
Other possibly contaminated batches have been reported in recent days, but experts say health risks are low.
Japan Times
JAPAN / FOCUS
Aug 24, 2021
Japan turns to antibody cocktails as 'new weapon' in fight against pandemic
The government has widened the use of the drug Ronapreve, but some doctors say it needs to go further and make it available to patients isolating at home too.
Japan Times
COMMENTARY / World
Aug 12, 2021
Can Moderna buy its way into the $200 billion club?
Moderna's COVID-19 windfall sees its market valuation surged by more than $100 billion since May.
Japan Times
JAPAN
Aug 11, 2021
Japan backs 'revolutionary' COVID-19 drug Ronapreve to help tame crisis
The antibody cocktail, intended for mildly and moderately ill patients, could in the near future be used to treat those quarantining at home, helping to ease the strain on hospitals.
Japan Times
BUSINESS / Companies
Aug 4, 2021
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
Japan Times
COMMENTARY / World
Jul 30, 2021
Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
Japan Times
JAPAN
Jul 29, 2021
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
Japan Times
WORLD / Science & Health / FOCUS
Jul 21, 2021
Global quest underway to speed up COVID-19 vaccine trials
Researchers are trying to determine just what level of antibodies a vaccine must produce to provide protection against the illness.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
WORLD
Jul 9, 2021
Pfizer outlines booster plans while regulators signal caution
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.
Japan Times
WORLD
Jul 9, 2021
Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters
Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.
Japan Times
BUSINESS / Companies
Jul 9, 2021
Fujifilm says pivot to health care and chips paid off in pandemic
Over the past decade, Fujifilm parlayed its expertise in film and chemicals to move into medical diagnostics, pharmaceutical manufacturing and supplying materials to chipmakers.
Japan Times
WORLD / Science & Health
Jul 7, 2021
Studies show vaccines are effective against delta variant
Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.
Japan Times
WORLD
Jun 20, 2021
Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths
In Sao Paulo, people demand the U.S. company's shots at public clinics and often walk out if none are available.
Japan Times
WORLD / Science & Health
Jun 20, 2021
Don’t count on needing a COVID-19 booster shot, top WHO scientist says
As some governments prepare for COVID-19 booster shots targeting more infectious virus variants, health authorities say it's too early to tell if they will be required.
Japan Times
WORLD / Science & Health
Jun 16, 2021
Regeneron drug reduces COVID-19 patient deaths in large study
The results suggest there would be six fewer deaths over 28 days for every 100 patients given the company's casirivimab and imdevimab combination of monoclonal antibodies.
Japan Times
ASIA PACIFIC
Jun 16, 2021
Why Asia, the pandemic champion, remains miles away from the finish line
All across the Asia-Pacific region, the countries that led the world in containing the coronavirus are now languishing in the race to put it behind them.
Japan Times
WORLD
Jun 15, 2021
Novavax COVID-19 shot highly effective against variants in trial
The company plans to apply for regulatory clearance globally, with much of the first available doses going to low- and middle-income countries.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?